Vaccines
1 April 2016
Medigene announces Start of Phase II trial with DC vaccines and upcoming milestone payment25 March 2016
New findings in humans provide encouraging foundation for upcoming AIDS vaccine clinical trial10 March 2016
Targovax announces encouraging interim results with RAS specific peptide vaccine in resected pancreatic cancer3 March 2016
Immunovaccine Initiates Zika Virus Vaccine Program Using Proprietary DepoVax(TM) Platform23 February 2016
OncBioMune Continuing Phase 1 Trial, While Initiating Phase 2 Trial of ProscaVax for Prostate Cancer23 February 2016
OBI Pharma Reports Topline Results From OBI-822/821 Randomized Controlled Phase 2/3 Clinical Trial In Patients With Metastatic Breast Cancer23 February 2016
OncoQR ML’s Pancreatic Cancer Vaccine TYG100 Induces Clinically Relevant Immune Response Within Just 2 Weeks After Single Vaccination19 February 2016
Phase 1b Clinical Trial of BPZE1 Pertussis Vaccine Completes Enrollment of Randomized Study Groups18 February 2016
NewLink Genetics Corporation Announces Project to Develop New Treatment Options for the Zika Virus18 February 2016
VALNEVA Evaluating Development of Zika Vaccine as Virus Spreads Through the Americas17 February 2016
Inovio Pharmaceutical’s DNA Vaccine for Zika Virus Induces Robust Immune Responses in Preclinical Study10 February 2016
Myasthenia gravis: CuraVac launches phase 1b study in patientsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports